SCHEMBL3129131

SCHEMBL3129131

CC(C)(C)c1cc(C(C)(C)C)c(Cl)c(O)c1O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 4/20 0.52
CA1 P00915 2/20 0.52
SMN1; SMN2 Q16637 6/20 0.50
ALDH1A1 P00352 5/20 0.50
POLB P06746 1/20 0.50
TYR P14679 1/20 0.50
GLRA3 O75311 1/20 0.48
GLRB P48167 1/20 0.48
CYP2C9 P11712 4/20 0.46
CYP2C19 P33261 4/20 0.46
HIF1A Q16665 3/20 0.46
TP53 P04637 2/20 0.46
CYP1A2 P05177 3/20 0.45
ALOX15 P16050 3/20 0.45
MAPT P10636 2/20 0.45
HPN P05981 1/20 0.45
SIRT5 Q9NXA8 1/20 0.45
KDM4E B2RXH2 1/20 0.44
ATP2A2 P16615 1/20 0.44
ATP2A3 Q93084 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9149388 0.85 CA2 (0.56) CA2CA1SMN1; SMN2ALDH1A1POLB
SCHEMBL23542373 0.84 SMN1; SMN2 (0.48) CA2CA1SMN1; SMN2ALDH1A1POLB
SCHEMBL20657093 0.82 CA2 (0.65) CA2CA1SMN1; SMN2ALDH1A1POLB
SCHEMBL26848563 0.80 ALOX15 (0.43) CA2CA1SMN1; SMN2ALDH1A1POLB
SCHEMBL10618591 0.77 SMN1; SMN2 (0.52) CA2CA1SMN1; SMN2ALDH1A1POLB
SCHEMBL4133977 0.76 GLRA3 (0.75) CA2CA1SMN1; SMN2ALDH1A1POLB
SCHEMBL47579 0.75 CA2 (0.64) CA2CA1SMN1; SMN2ALDH1A1POLB
SCHEMBL28803391 0.75 ALOX15 (0.50) CA2CA1SMN1; SMN2ALDH1A1POLB
SCHEMBL24946528 0.74 SMN1; SMN2 (0.53) CA2CA1SMN1; SMN2ALDH1A1POLB
SCHEMBL29462687 0.74 CA2 (0.62) CA2CA1SMN1; SMN2ALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7247687-B2 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2007-07-24 US claimed
EP-1521758-B1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEM PATENTS INC (US) 2006-05-24 EP claimed
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization EXXONMOBIL CHEMICAL PATENTS INC. 2006-03-02 US claimed
EP-1521758-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION Exxonmobil Chemical Patents Inc. (US) 2005-04-13 EP claimed
WO-2004007509-A1 LATE TRANSITION METAL CATALYSTS FOR OLEFIN POLYMERIZATION AND OLIGOMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2004-01-22 WO claimed
EP-1697446-B1 METHOD OF TREATING A PLASTIC ARTICLE BAYER MATERIALSCIENCE LLC (US) 2015-08-19 EP disclosed
EP-2067060-B1 AN ARTICLE HAVING PHOTOCHROMIC PROPERTIES AND PROCESS FOR ITS MANUFACTURE BAYER MATERIALSCIENCE LLC (US) 2010-07-07 EP disclosed
EP-2067060-A2 AN ARTICLE HAVING PHOTOCHROMIC PROPERTIES AND PROCESS FOR ITS MANUFACTURE Bayer MaterialScience LLC (US) 2009-06-10 EP disclosed
US-7504054-B2 Method of treating a plastic article BAYER MATERIALSCIENCE LLC (US) 2009-03-17 US disclosed
EP-2016119-A1 METHOD OF TREATING A PLASTIC ARTICLE Bayer MaterialScience LLC (US) 2009-01-21 EP disclosed
WO-2008070056-A2 METHOD OF DYEING A SEMI-FINISHED PRODUCT BAYER MATERIALSCIENCE LLC (US) 2008-06-12 WO disclosed
EP-1899410-A2 PROCESS FOR THE TREATMENT OF PLASTICS PROFILES Bayer MaterialScience AG (DE) 2008-03-19 EP disclosed
WO-2003037998-A1 ARTICLES HAVING A PHOTOCHROMIC POLYMERIC COATING TRANSITIONS OPTICAL, INC. (US) 2003-05-08 WO disclosed
US-20030045612-A1 Organic photochromic compositions of improved kinetic performance TRANSITIONS OPTICAL LIMITED (IE) 2003-03-06 US disclosed
EP-1276780-A2 POLYMERIZABLE COMPOSITION OF ALLYL FUNCTIONAL MONOMERS PPG Industries Ohio, Inc. (US) 2003-01-22 EP disclosed
US-6506864-B1 Polyether diol bis(allyl carbonate) and/or polylactone diol bis(allyl carbonate); photochromism PPG INDUSTRIES OHIO, INC. 2003-01-14 US disclosed
EP-1196466-A1 POLYMERIZABLE COMPOSITION OF ALIPHATIC POLYOL (ALLYL CARBONATE) PPG Industries Ohio, Inc. (US) 2002-04-17 EP disclosed
US-6316570-B1 FOR PRODUCING POLYMERIZATES HAVING CLARITY, GOOD FLEXIBILITY, ABRASION RESISTANCE WHICH ARE USED IN PREPARATION OF MOLDED ARTICLES SUCH AS LENSES PPG INDUSTRIES OHIO, INC. 2001-11-13 US disclosed
WO-2001077194-A2 POLYMERIZABLE COMPOSITION OF ALLYL FUNCTIONAL MONOMERS PPG INDUSTRIES OHIO, INC. (US) 2001-10-18 WO disclosed
WO-2000078832-A1 POLYMERIZABLE COMPOSITION OF ALIPHATIC POLYOL (ALLYL CARBONATE) PPG INDUSTRIES OHIO, INC. (US) 2000-12-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060047094-A1 Late transition metal catalysts for olefin polymerization and oligomerization MLX, LOX, LMTK3 CA2 2455/4885CA1 3572/4885SMN1; SMN2 3076/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.